Tango Therapeutics annual current ratio
2020
2021
2022
2023
2024
2025
Tango Therapeutics Current Ratio Growth & History (TNGX)
Tango Therapeutics's current ratio was 16.32 for fiscal 2025.
View full Tango Therapeutics company overviewTango Therapeutics annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 16.32 | 9.34 | +133.85% |
| 2024 | 2024-12-31 | 6.98 | −0.57 | −7.50% |
| 2023 | 2023-12-31 | 7.54 | 0.79 | +11.65% |
| 2022 | 2022-12-31 | 6.76 | −5.34 | −44.16% |
| 2021 | 2021-12-31 | 12.10 | 7.37 | +155.68% |
| 2020 | 2020-12-31 | 4.73 | — | — |
Tango Therapeutics quarterly current ratio
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 50.82 | 46.07 | +970.08% |
| Q1 2026 | 2026-03-31 | 27.38 | 21.12 | +337.17% |
| Q4 2025 | 2025-12-31 | 16.32 | 9.34 | +133.85% |
| Q3 2025 | 2025-09-30 | 8.88 | 0.88 | +10.94% |
| Q2 2025 | 2025-06-30 | 4.75 | −2.74 | −36.56% |
| Q1 2025 | 2025-03-31 | 6.26 | −1.96 | −23.88% |
| Q4 2024 | 2024-12-31 | 6.98 | −0.57 | −7.50% |
| Q3 2024 | 2024-09-30 | 8.00 | −0.54 | −6.31% |
| Q2 2024 | 2024-06-30 | 7.49 | 1.51 | +25.26% |
| Q1 2024 | 2024-03-31 | 8.23 | 1.84 | +28.74% |
| Q4 2023 | 2023-12-31 | 7.54 | 0.79 | +11.65% |
| Q3 2023 | 2023-09-30 | 8.54 | 0.72 | +9.15% |
| Q2 2023 | 2023-06-30 | 5.98 | −3.78 | −38.76% |
| Q1 2023 | 2023-03-31 | 6.39 | −5.36 | −45.60% |
| Q4 2022 | 2022-12-31 | 6.76 | −5.34 | −44.16% |
| Q3 2022 | 2022-09-30 | 7.83 | −4.47 | −36.36% |
| Q2 2022 | 2022-06-30 | 9.76 | 7.69 | +372.10% |
| Q1 2022 | 2022-03-31 | 11.75 | 6.94 | +144.44% |
| Q4 2021 | 2021-12-31 | 12.10 | 7.37 | +155.68% |
| Q3 2021 | 2021-09-30 | 12.30 | −1.80 | −12.76% |
| Q2 2021 | 2021-06-30 | 2.07 | — | — |
| Q1 2021 | 2021-03-31 | 4.81 | — | — |
| Q4 2020 | 2020-12-31 | 4.73 | — | — |
| Q3 2020 | 2020-09-30 | 14.10 | — | — |
Tango Therapeutics current ratio trends
Over the last five fiscal years, Tango Therapeutics's current ratio increased from 4.73 to 16.32, a change of 11.59. The latest reported quarter, Q2 2026, shows 50.82.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tango Therapeutics source filings ↗